A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
E. Turro, D. Greene, A. Wijgaerts, C. Thys, C. Lentaigne, T.K. Bariana, S.K. Westbury, A.M. Kelly, D. Selleslag, J.C. Stephens, S. Papadia, I. Simeoni, C.J. Penkett, S. Ashford, A. Attwood, S. Austin, T. Bakchoul, P. Collins, S.V.V. Deevi, R. FavierM. Kostadima, M.P. Lambert, M. Mathias, C.M. Millar, K. Peerlinck, D.J. Perry, S. Schulman, D. Whitehorn, C. Wittevrongel, M. De Maeyer, A. Rendon, K. Gomez, Wendy N. Erber, A.D. Mumford, P. Nurden, K. Stirrups, J.R. Bradley, F.L. Raymond, M.A. Laffan, C. Van Geet, S. Richardson, K. Freson, H. Ouwehand
Dive into the research topics of 'A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies'. Together they form a unique fingerprint.